Format
Sort by
Items per page

Send to

Choose Destination

Links from PubMed

Items: 1 to 20 of 80

1.

Approval summary: nelarabine for the treatment of T-cell lymphoblastic leukemia/lymphoma.

Cohen MH, Johnson JR, Massie T, Sridhara R, McGuinn WD Jr, Abraham S, Booth BP, Goheer MA, Morse D, Chen XH, Chidambaram N, Kenna L, Gobburu JV, Justice R, Pazdur R.

Clin Cancer Res. 2006 Sep 15;12(18):5329-35.

2.

Nelarabine: efficacy in the treatment of clinical malignancies.

Roecker AM, Allison JC, Kisor DF.

Future Oncol. 2006 Aug;2(4):441-8. Review.

PMID:
16922610
3.

Consensus guidelines for microarray gene expression analyses in leukemia from three European leukemia networks.

Staal FJ, Cario G, Cazzaniga G, Haferlach T, Heuser M, Hofmann WK, Mills K, Schrappe M, Stanulla M, Wingen LU, van Dongen JJ, Schlegelberger B.

Leukemia. 2006 Aug;20(8):1385-92. Epub 2006 Jun 8.

PMID:
16761018
4.

Gene expression signature of primary imatinib-resistant chronic myeloid leukemia patients.

Frank O, Brors B, Fabarius A, Li L, Haak M, Merk S, Schwindel U, Zheng C, Müller MC, Gretz N, Hehlmann R, Hochhaus A, Seifarth W.

Leukemia. 2006 Aug;20(8):1400-7. Epub 2006 May 25.

PMID:
16728981
5.

Transcriptional regulatory networks downstream of TAL1/SCL in T-cell acute lymphoblastic leukemia.

Palomero T, Odom DT, O'Neil J, Ferrando AA, Margolin A, Neuberg DS, Winter SS, Larson RS, Li W, Liu XS, Young RA, Look AT.

Blood. 2006 Aug 1;108(3):986-92. Epub 2006 Apr 18.

6.

Activating NOTCH1 mutations predict favorable early treatment response and long-term outcome in childhood precursor T-cell lymphoblastic leukemia.

Breit S, Stanulla M, Flohr T, Schrappe M, Ludwig WD, Tolle G, Happich M, Muckenthaler MU, Kulozik AE.

Blood. 2006 Aug 15;108(4):1151-7. Epub 2006 Apr 13.

7.

Notch 1 activation in the molecular pathogenesis of T-cell acute lymphoblastic leukaemia.

Grabher C, von Boehmer H, Look AT.

Nat Rev Cancer. 2006 May;6(5):347-59. Review.

PMID:
16612405
8.

Stem cells in the etiology and treatment of cancer.

Zhang M, Rosen JM.

Curr Opin Genet Dev. 2006 Feb;16(1):60-4. Epub 2005 Dec 27. Review.

PMID:
16377171
9.

Microarray data analysis: from disarray to consolidation and consensus.

Allison DB, Cui X, Page GP, Sabripour M.

Nat Rev Genet. 2006 Jan;7(1):55-65. Review. Erratum in: Nat Rev Genet. 2006 May;7(5):406.

PMID:
16369572
10.

Childhood acute lymphoblastic leukemia in the age of genomics.

Carroll WL, Bhojwani D, Min DJ, Moskowitz N, Raetz EA.

Pediatr Blood Cancer. 2006 May 1;46(5):570-8. Review.

PMID:
16365862
11.

Gene expression profiling reveals intrinsic differences between T-cell acute lymphoblastic leukemia and T-cell lymphoblastic lymphoma.

Raetz EA, Perkins SL, Bhojwani D, Smock K, Philip M, Carroll WL, Min DJ.

Pediatr Blood Cancer. 2006 Aug;47(2):130-40.

PMID:
16358311
12.

Antimetabolite-based therapy in childhood T-cell acute lymphoblastic leukemia: a report of POG study 9296.

Winter SS, Holdsworth MT, Devidas M, Raisch DW, Chauvenet A, Ravindranath Y, Ducore JM, Amylon MD.

Pediatr Blood Cancer. 2006 Feb;46(2):179-86.

PMID:
16007607
13.

Phase II study of nelarabine (compound 506U78) in children and young adults with refractory T-cell malignancies: a report from the Children's Oncology Group.

Berg SL, Blaney SM, Devidas M, Lampkin TA, Murgo A, Bernstein M, Billett A, Kurtzberg J, Reaman G, Gaynon P, Whitlock J, Krailo M, Harris MB; Children's Oncology Group.

J Clin Oncol. 2005 May 20;23(15):3376-82.

PMID:
15908649
14.

Immunophenotypic cell lineage and in vitro cellular drug resistance in childhood relapsed acute lymphoblastic leukaemia.

Kaspers GJ, Wijnands JJ, Hartmann R, Huismans L, Loonen AH, Stackelberg A, Henze G, Pieters R, Hählen K, Van Wering ER, Veerman AJ.

Eur J Cancer. 2005 Jun;41(9):1300-3.

PMID:
15869873
15.

Gene expression levels assessed by oligonucleotide microarray analysis and quantitative real-time RT-PCR -- how well do they correlate?

Dallas PB, Gottardo NG, Firth MJ, Beesley AH, Hoffmann K, Terry PA, Freitas JR, Boag JM, Cummings AJ, Kees UR.

BMC Genomics. 2005 Apr 27;6:59.

16.

Identification of genes associated with chemotherapy crossresistance and treatment response in childhood acute lymphoblastic leukemia.

Lugthart S, Cheok MH, den Boer ML, Yang W, Holleman A, Cheng C, Pui CH, Relling MV, Janka-Schaub GE, Pieters R, Evans WE.

Cancer Cell. 2005 Apr;7(4):375-86.

17.
18.

Pharmacogenetics of outcome in children with acute lymphoblastic leukemia.

Rocha JC, Cheng C, Liu W, Kishi S, Das S, Cook EH, Sandlund JT, Rubnitz J, Ribeiro R, Campana D, Pui CH, Evans WE, Relling MV.

Blood. 2005 Jun 15;105(12):4752-8. Epub 2005 Feb 15.

19.

Intercellular transfer of P-glycoprotein mediates acquired multidrug resistance in tumor cells.

Levchenko A, Mehta BM, Niu X, Kang G, Villafania L, Way D, Polycarpe D, Sadelain M, Larson SM.

Proc Natl Acad Sci U S A. 2005 Feb 8;102(6):1933-8. Epub 2005 Jan 25.

20.

A genome-wide view of the in vitro response to l-asparaginase in acute lymphoblastic leukemia.

Fine BM, Kaspers GJ, Ho M, Loonen AH, Boxer LM.

Cancer Res. 2005 Jan 1;65(1):291-9.

Supplemental Content

Support Center